Immune Response to Conjugates of Fragments of the Type K9 Capsular Polysaccharide of Acinetobacter baumannii with Carrier Proteins

Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice

(2021) Xin Li et al.   Microbial Biotechnology

Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development

(2021) NorAziyah Mat Rahim et al.   Human Vaccines & Immunotherapeutics

Synthetic Pseudaminic-Acid-Based Antibacterial Vaccine Confers Effective Protection against Acinetobacter baumannii Infection

(2021) Ruohan Wei et al.   ACS Central Science

Acinetobacter baumannii Infections in Times of COVID-19 Pandemic

(2021) Karyne Rangel et al.   Pathogens

The K26 capsular polysaccharide from Acinetobacter baumannii KZ-1098: Structure and cleavage by a specific phage depolymerase

(2021) Anastasiya A. Kasimova et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Acinetobacter baumannii

(2021) Clémence Whiteway et al.   TRENDS IN MICROBIOLOGY

IL-10 Protects Mice From the Lung Infection of Acinetobacter baumannii and Contributes to Bacterial Clearance by Regulating STAT3-Mediated MARCO Expression in Macrophages

(2020) Min-Jung Kang et al.   Frontiers in Immunology

Mechanisms of Acinetobacter baumannii Capsular Polysaccharide Cleavage by Phage Depolymerases

(2020) Y. A. Knirel et al.   BIOCHEMISTRY-MOSCOW

Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU

(2020) Ehsan Sharifipour et al.   BMC INFECTIOUS DISEASES

Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine

(2020) Patrick S. Gellings et al.   Pathogens

Surface-Related Features and Virulence Among Acinetobacter baumannii Clinical Isolates Belonging to International Clones I and II

(2019) Jūratė Skerniškytė et al.   Frontiers in Microbiology

Glycoconjugates: What It Would Take To Master These Well-Known yet Little-Understood Immunogens for Vaccine Development

(2019) Fikri Avci et al.   mSphere

Structure of the K128 capsular polysaccharide produced by Acinetobacter baumannii KZ-1093 from Kazakhstan

(2019) Nikolay P. Arbatsky et al.   CARBOHYDRATE RESEARCH

Comparative analysis of humoral immune responses and pathologies of BALB/c and C57BL/6 wildtype mice experimentally infected with a highly virulent Rodentibacter pneumotropicus (Pasteurella pneumotropica) strain

(2018) Juliane Fornefett et al.   BMC MICROBIOLOGY

Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies

(2018) Taylor C. Stevenson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of T helper (Th)1- and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection

(2018) Carolina Firacative et al.   Scientific Reports

Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles

(2018) Nicholas J. Croucher et al.   Annual Review of Microbiology

IgG subclasses determine pathways of anaphylaxis in mice

(2017) Héloïse Beutier et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Clinical Isolates of Acinetobacter baumannii From Tehran Hospitals: Pulsed-field Gel Electrophoresis Characterization, Clonal Lineages, Antibiotic Susceptibility, and Biofilm-forming Ability

(2017) Mahdi Akbari Dehbalaei et al.   Jundishapur Journal of Microbiology

Calcium phosphate: a substitute for aluminum adjuvants?

(2016) Jean-Daniel Masson et al.   Expert Review of Vaccines

Acinetobacter baumanniiInfection and IL-17 Mediated Immunity

(2016) Zihe Yan et al.   MEDIATORS OF INFLAMMATION

Effect of murine exposure to gamma rays on the interplay between Th1 and Th2 lymphocytes

(2015) Amany A. Ghazy et al.   Frontiers in Pharmacology

Glycoconjugate vaccines: an update

(2014) Mairi Vella et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Evolving meningococcal immunization strategies

(2014) Marco Aurélio Sáfadi et al.   Expert Review of Vaccines

Distribution of OXA-Type Class D β-Lactamase Genes Among Nosocomial Multi Drug Resistant Acinetobacter baumannii Isolated in Tehran Hospitals

(2013) Afsaneh Karmostaji et al.   Jundishapur Journal of Microbiology

Acinetobacter baumannii: evolution of a global pathogen

(2013) Luísa C.S. Antunes et al.   Pathogens and Disease

Properties of mouse and human IgG receptors and their contribution to disease models

(2012) P. Bruhns   BLOOD

Identification and structural determination of the capsular polysaccharides from two Acinetobacter baumannii clinical isolates, MG1 and SMAL

(2011) Eleonora Fregolino et al.   CARBOHYDRATE RESEARCH

The design of semi-synthetic and synthetic glycoconjugate vaccines

(2011) Paolo Costantino et al.   Expert Opinion on Drug Discovery

Poly-N-Acetyl-β-(1-6)-Glucosamine Is a Target for Protective Immunity against Acinetobacter baumannii Infections

(2011) Leticia V. Bentancor et al.   INFECTION AND IMMUNITY

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design

(2011) Fikri Y Avci et al.   NATURE MEDICINE

Immunological Variation Between Inbred Laboratory Mouse Strains

(2011) R. S. Sellers et al.   VETERINARY PATHOLOGY

Carbohydrate vaccines: developing sweet solutions to sticky situations?

(2010) Rena D. Astronomo et al.   NATURE REVIEWS DRUG DISCOVERY

Chemoselective Reagents for Covalent Capture and Display of Glycans in Microarrays

(2009) Emiliano Cló et al.   EUROPEAN JOURNAL OF ORGANIC CHEMISTRY

Streptococcus suis Bacterin and Subunit Vaccine Immunogenicities and Protective Efficacies against Serotypes 2 and 9

(2008) C. G. Baums et al.   Clinical and Vaccine Immunology

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS

Haemophilus influenzae type b conjugate vaccine use and effectiveness

(2008) Shaun K Morris et al.   LANCET INFECTIOUS DISEASES